MCL1 (Myeloid Cell Leukemia 1) is an anti-apoptotic protein belonging to the BCL2 family that plays critical roles in regulating mitochondrial apoptosis and cellular survival. In the nervous system, MCL1 provides essential neuroprotection, and its dysregulation contributes to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD). Unlike other BCL2 family members, MCL1 has an exceptionally short half-life, allowing rapid response to cellular stress signals.
| MCL1 Protein |
|---|
| Protein Name | MCL1 |
| Gene | [MCL1](/genes/mcl1) |
| UniProt ID | [Q07820](https://www.uniprot.org/uniprot/Q07820) |
| PDB ID | 2JM5, 4G35, 5JSB |
| Molecular Weight | 37 kDa (long isoform) |
| Subcellular Localization | Mitochondria, ER |
| Protein Family | BCL2 family |
| Aliases | E1, MCL1L, MCL1S |
MCL1 contains several distinctive features:
- BH1, BH2, BH3, BH4 Domains: Characteristic of anti-apoptotic BCL2 proteins
- N-terminal PEST Sequences: Multiple PEST regions (rich in Proline, Glutamate, Serine, Threonine) target MCL1 for rapid ubiquitin-dependent degradation
- NLR (N-terminal Leu-rich) Region: Unique to MCL1, involved in protein interactions
- Kinetics: Short half-life (~30 minutes) allows dynamic regulation
MCL1 inhibits apoptosis through multiple mechanisms:
- Direct Sequestration: Binds and inhibits pro-apoptotic BAX, BAK1, and BH3-only proteins (BIM, NOXA, PUMA)
- Mitochondrial Protection: Prevents mitochondrial outer membrane permeabilization (MOMP)
- ER Regulation: Controls ER stress-induced apoptosis
- Cell Survival: Essential for survival of various cell types including neurons
- Development: Critical for embryonic development (knockout is embryonic lethal)
- Immune Cell Maintenance: Required for lymphocyte survival and differentiation
- Stem Cell Biology: Important for hematopoietic stem cell function
MCL1 is particularly important in ALS:
- Motor Neuron Vulnerability: MCL1 provides essential protection for motor neurons [1]
- Reduced Expression: MCL1 levels are reduced in ALS models and patient tissue
- Therapeutic Target: Enhancing MCL1 protects motor neurons in preclinical models
In AD, MCL1 dysregulation contributes to neuronal loss:
- Impaired Regulation: Altered MCL1 expression and post-translational modification
- Amyloid-β Interaction: Aβ toxicity affects MCL1 stability
- Synaptic Protection: MCL1 protects synapses from apoptotic death
In PD, MCL1 plays protective roles:
- Dopaminergic Neuron Survival: MCL1 protects substantia nigra neurons
- α-Synuclein Toxicity: Modulates vulnerability to α-synuclein aggregation
- Mitochondrial Protection: Supports mitochondrial health in dopaminergic neurons
| Condition |
Role of MCL1 |
| Huntington's Disease |
Reduced, contributes to neuronal death |
| Stroke/Ischemia |
Protective when upregulated |
| Multiple Sclerosis |
Protects oligodendrocytes |
Enhancing MCL1 activity or stability could provide neuroprotection without completely blocking apoptosis (which is needed for normal immune function).
- MCL1 Stabilizers: Small molecules that prevent MCL1 degradation
- Upstream Modulators: Activate signaling pathways that increase MCL1 expression
- Combination Therapy: MCL1 enhancement with other neuroprotective strategies
- Selectivity: Must avoid complete apoptosis blockade
- CNS Delivery: Therapeutic agents must cross the blood-brain barrier
- Temporal Window: Early intervention may be most effective
- BAX: Primary target for inhibition
- BAK1: Also inhibited by MCL1
- BIM: Potent pro-apoptotic binder
- NOXA: Specific binder (MCL1 has lower affinity for NOXA)
- PUMA: Strong activator
- MULE: E3 ubiquitin ligase targeting MCL1 for degradation
- EBP: Co-chaperone regulating MCL1 function
- BCL2: Functional partner
- Liu J, et al. (2009). MCL1 function in ALS. Nat Neurosci 12: 1064-1073
- Kelly GL, et al. (2010). MCL1 in cancer biology. Nat Rev Cancer 10: 825-835
- Wei MC, et al. (2001). Proapoptotic activation and killing. Cell 103: 645-656
- Liu J, et al. (2009). MCL1 function in ALS. Nat Neurosci 12: 1064-1073.
- Kelly GL, et al. (2010). MCL1 in cancer biology. Nat Rev Cancer 10: 825-835.
- Wei MC, et al. (2001). Proapoptotic activation and killing. Cell 103: 645-656.